Vitamin B2 vs Cancer, Clotting Risks, and New Hope for Resistant Hypertension

Today we cover a striking vitamin B2 discovery in cancer immunology from Cell, a Circulation review on anticancer drugs and blood clots, and new guidance on resistant hypertension from the Clinical Journal of the American Society of Nephrology. We also look at expanding treatment options for beta thalassemia, a shift toward using precision cancer drugs before surgery, and a practical approach to hypertensive emergencies in critically ill patients. A quick rundown covers six more papers on topics from gut bacteria and cognition to endometriosis imaging.